Hartford Financial Management Inc. lessened its position in shares of Danaher Co. (NYSE:DHR – Free Report) by 5.8% during the 3rd quarter, HoldingsChannel reports. The fund owned 15,116 shares of the conglomerate’s stock after selling 926 shares during the quarter. Hartford Financial Management Inc.’s holdings in Danaher were worth $4,203,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $25,000. nVerses Capital LLC acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $25,000. MFA Wealth Advisors LLC acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $51,000. Financial Connections Group Inc. acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new stake in shares of Danaher during the 1st quarter worth approximately $55,000. Institutional investors own 79.05% of the company’s stock.
Insiders Place Their Bets
In other Danaher news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 11.10% of the company’s stock.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on DHR
Danaher Stock Performance
Shares of DHR stock opened at $245.66 on Friday. The company’s fifty day simple moving average is $267.38 and its 200-day simple moving average is $260.32. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm has a market cap of $177.44 billion, a PE ratio of 46.88, a P/E/G ratio of 4.45 and a beta of 0.83. Danaher Co. has a 12 month low of $188.75 and a 12 month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the previous year, the firm posted $2.02 earnings per share. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. Equities research analysts expect that Danaher Co. will post 7.51 EPS for the current fiscal year.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Stories
- Five stocks we like better than Danaher
- What is a Stock Market Index and How Do You Use Them?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
- What Are the FAANG Stocks and Are They Good Investments?
- Apple Earnings – When Really Good Just Isn’t Good Enough
- Where to Find Earnings Call Transcripts
- Starbucks Stock Primed for Growth Under New CEO Niccol’s Vision
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.